Scimago Journal & Country Rank
menu
| Title | Type | SJR | H index | Total Docs. (2016) | Total Docs. (3years) | Total Refs. (2016) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) |  Ref. / Doc. (2016) |
||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 51 | Current Pharmacology Reports | journal | 0.702 Q2 | 35 | 34 | 42 | 3104 | 102 | 42 | 2.43 | 91.29 |  |
| 52 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.041 Q1 | 52 | 34 | 73 | 3074 | 256 | 69 | 3.29 | 90.41 |  |
| 53 | Methods in Pharmacology and Toxicology | book series | 0.129 Q3 | 14 | 119 | 133 | 10654 | 42 | 120 | 0.32 | 89.53 |  |
| 54 | Expert Opinion on Therapeutic Patents | journal | 1.057 Q1 | 88 | 110 | 328 | 9821 | 1305 | 325 | 3.16 | 89.28 |  |
| 55 | Expert Opinion on Investigational Drugs | journal | 1.210 Q1 | 117 | 126 | 411 | 11124 | 1545 | 405 | 3.80 | 88.29 | |
| 56 | Trends in Pharmacological Sciences | journal | 5.350 Q1 | 244 | 97 | 267 | 8367 | 2852 | 211 | 11.06 | 86.26 | |
| 57 | Current Gene Therapy | journal | 1.323 Q1 | 80 | 43 | 143 | 3620 | 462 | 134 | 3.06 | 84.19 | |
| 58 | CNS and Neurological Disorders - Drug Targets | journal | 1.003 Q2 | 96 | 144 | 500 | 12082 | 1247 | 440 | 2.47 | 83.90 | |
| 59 | Issues in Toxicology | book series | 0.110 Q4 | 18 | 76 | 133 | 6325 | 16 | 121 | 0.10 | 83.22 | |
| 60 | NTP Research Report Series | book series | 3 | 2 | 0 | 165 | 0 | 0 | 0.00 | 82.50 | | |
| 61 | Expert Review of Precision Medicine and Drug Development | journal | 16 | 52 | 0 | 4245 | 0 | 0 | 0.00 | 81.63 | | |
| 62 | Expert Opinion on Biological Therapy | journal | 1.167 Q1 | 102 | 139 | 502 | 11318 | 1752 | 489 | 3.43 | 81.42 | |
| 63 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.928 Q2 | 100 | 138 | 403 | 11225 | 1389 | 399 | 3.40 | 81.34 | |
| 64 | Expert Opinion on Drug Delivery | journal | 1.488 Q1 | 133 | 147 | 406 | 11820 | 2413 | 397 | 5.70 | 80.41 | |
| 65 | Pharmaceuticals | journal | 1.553 Q1 | 87 | 77 | 172 | 6189 | 897 | 165 | 4.62 | 80.38 | |
| 66 | Expert Review of Vaccines | journal | 1.482 Q1 | 105 | 141 | 416 | 11331 | 1366 | 386 | 3.31 | 80.36 | |
| 67 | Pharmacological Research | journal | 2.037 Q1 | 169 | 406 | 438 | 32415 | 2440 | 422 | 4.95 | 79.84 | |
| 68 | PharmaNutrition | journal | 0.613 Q3 | 30 | 18 | 72 | 1392 | 149 | 67 | 1.72 | 77.33 |  |
| 69 | Journal of Pharmacy and Pharmaceutical Sciences | journal | 0.592 Q2 | 88 | 40 | 156 | 3079 | 363 | 155 | 1.73 | 76.98 |  |
| 70 | Expert Opinion on Orphan Drugs | journal | 0.268 Q2 | 27 | 129 | 354 | 9882 | 205 | 350 | 0.56 | 76.60 | |
| 71 | Neurotoxicity Research | journal | 1.142 Q1 | 84 | 101 | 216 | 7576 | 727 | 215 | 3.10 | 75.01 | |
| 72 | Expert Opinion on Pharmacotherapy | journal | 1.014 Q2 | 93 | 238 | 734 | 17781 | 2325 | 715 | 3.40 | 74.71 | |
| 73 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 15 | 69 | 1119 | 78 | 65 | 0.96 | 74.60 | | |
| 74 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.587 Q2 | 28 | 20 | 61 | 1492 | 119 | 59 | 1.76 | 74.60 | |
| 75 | Core Evidence (discontinued) | journal | 0.965 Q2 | 29 | 5 | 28 | 371 | 116 | 27 | 4.24 | 74.20 |  |
| 76 | Pharmacognosy Reviews (discontinued) | journal | 1.140 Q1 | 68 | 20 | 68 | 1475 | 314 | 67 | 4.72 | 73.75 |  |
| 77 | Drug Discovery Today | journal | 2.170 Q1 | 215 | 209 | 586 | 15377 | 3856 | 544 | 6.41 | 73.57 | |
| 78 | Chinese Herbal Medicines | journal | 18 | 1 | 0 | 73 | 0 | 0 | 0.00 | 73.00 | | |
| 79 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 35 | 134 | 2490 | 247 | 122 | 1.59 | 71.14 | | |
| 80 | Expert Review of Clinical Pharmacology | journal | 1.040 Q1 | 60 | 156 | 228 | 11087 | 661 | 208 | 2.84 | 71.07 | |
| 81 | PPAR Research | journal | 1.079 Q1 | 59 | 31 | 88 | 2200 | 248 | 85 | 2.87 | 70.97 | |
| 82 | Neuropharmacology | journal | 2.355 Q1 | 191 | 433 | 1229 | 30501 | 6354 | 1206 | 5.25 | 70.44 | |
| 83 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 22 | 70 | 1540 | 91 | 66 | 1.38 | 70.00 | | |
| 84 | Toxics | journal | 51 | 28 | 60 | 1908 | 111 | 58 | 1.94 | 68.14 | | |
| 85 | British Journal of Pharmacology | journal | 2.670 Q1 | 244 | 257 | 1302 | 17373 | 7083 | 1276 | 5.52 | 67.60 | |
| 86 | Future Medicinal Chemistry | journal | 0.970 Q2 | 90 | 165 | 564 | 11139 | 1450 | 450 | 2.63 | 67.51 | |
| 87 | Marine Drugs | journal | 0.883 Q2 | 159 | 234 | 1028 | 15798 | 4269 | 1026 | 4.08 | 67.51 | |
| 88 | AAPS Advances in the Pharmaceutical Sciences Series | book series | 0.201 Q3 | 18 | 89 | 232 | 5980 | 70 | 227 | 0.30 | 67.19 |  |
| 89 | Particle and Fibre Toxicology | journal | 2.755 Q1 | 119 | 67 | 171 | 4492 | 1746 | 166 | 9.10 | 67.04 | |
| 90 | Archives of Toxicology | journal | 1.758 Q1 | 141 | 228 | 565 | 15263 | 2889 | 467 | 4.74 | 66.94 | |
| 91 | Journal of Controlled Release | journal | 2.463 Q1 | 313 | 527 | 1436 | 35222 | 11749 | 1350 | 7.94 | 66.83 | |
| 92 | Cancer Nanotechnology | journal | 0.875 Q1 | 36 | 11 | 26 | 733 | 118 | 26 | 5.64 | 66.64 | |
| 93 | Anti-Cancer Agents in Medicinal Chemistry | journal | 0.807 Q2 | 108 | 198 | 464 | 13188 | 1248 | 429 | 2.43 | 66.61 | |
| 94 | Antibiotics | journal | 0.714 Q1 | 77 | 37 | 111 | 2457 | 234 | 108 | 2.08 | 66.41 | |
| 95 | Experimental and Clinical Psychopharmacology | journal | 1.275 Q1 | 101 | 47 | 170 | 3081 | 431 | 167 | 2.45 | 65.55 | |
| 96 | Frontiers in Pharmacology | journal | 1.729 Q1 | 154 | 515 | 725 | 33384 | 3101 | 671 | 4.37 | 64.82 | |
| 97 | Molecular Pharmacology | journal | 2.199 Q1 | 210 | 136 | 560 | 8804 | 2442 | 560 | 4.21 | 64.74 | |
| 98 | EPMA Journal | journal | 0.814 Q2 | 52 | 23 | 54 | 1479 | 245 | 54 | 3.70 | 64.30 | |
| 99 | Current Vascular Pharmacology | journal | 0.890 Q2 | 69 | 87 | 299 | 5574 | 629 | 252 | 2.15 | 64.07 | |
| 100 | Current Pharmaceutical Biotechnology | journal | 0.636 Q2 | 97 | 152 | 393 | 9634 | 834 | 358 | 2.23 | 63.38 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data